AMH is a better predictor of ovarian response than AFC: Against

Ovarian response prediction may be advantageous if the predicted response may be prevented or the inherent risks may be managed. In ART today, high/excessive response is the only condition to predict as OHSS prevention may be improved by prior knowledge of this risk condition. The scientific literature on the AFC and serum AMH, markers of the number of FSH responsive antral follicles, demonstrates equal accuracy. AMH- and AFC-based individualised FSH dosing studies have revealed equal effects on safety outcome measures compared to standard dosing. However, with the preference for antagonist cycles, OHSS preventive management is well possible without any prior ovarian response testing, making both tests equally futile.